Related Experiment Video

Updated: Apr 12, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

1.1K

From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications

Marta Gutiérrez-Rodríguez, Rosario Herranz1

  • 1Instituto de Química Médica (CSIC), Juan de la Cierva 3, E-28006 Madrid, Spain. rosario@iqm.csic.es.

Current Topics in Medicinal Chemistry
|May 20, 2015
PubMed

Insights

Protease-activated receptor 1 (PAR1) is a complex G protein-coupled receptor activated by proteases or peptides. Its diverse signaling pathways and interactions impact various physiological and pathological states, offering therapeutic potential.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Protease-activated receptor 1 (PAR1) is a G protein-coupled receptor (GPCR).
  • PAR1 activation involves proteolytic cleavage of its extracellular N-terminus, exposing a tethered ligand.
  • Thrombin is a primary PAR1 activator, but other proteases and PAR-activating peptides (PAR-APs) can also activate it.

Purpose of the Study:

  • To provide a comprehensive overview of the PAR1 interactome.
  • To explore the therapeutic implications of PAR1 modulation in various diseases.
  • To discuss agonists and antagonists targeting PAR1.

Main Methods:

  • Review of existing literature on PAR1 signaling.
  • Analysis of PAR1's interactions with G proteins and β-arrestin.
  • Examination of PAR1's role in different physiological and pathological contexts.

Main Results:

  • PAR1 exhibits complex signaling via G proteins and β-arrestin pathways.
  • PAR1 activation is modulated by receptor desensitization, trafficking, and degradation.
  • PAR1 shows species-, cellular-, and state-dependent specificity.

Conclusions:

  • PAR1's intricate interactome influences cardiovascular, immune, nervous, inflammatory, and cancer systems.
  • Understanding PAR1 signaling is crucial for developing targeted therapies.
  • PAR1 agonists and antagonists represent potential therapeutic agents.

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

15.9K
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

4.1K

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.0K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
617
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
20.0K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

2.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.5K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.6K